TABLE 1.

Demographic information for SSD-CI subjects.

Participant	Lab code	Dur deaf (yrs)	CI exp (yrs)	Etiology	Device	Strategy	CI ear	Non-CI ear PTA (dB HL)	CI ear CNC % correct
C1	SSD-C1	2.6	3.01	Idiopathic SSHL	AB HiRes90k Mid Scala	HiRes Optima-P	R	8.3	30
M2	SSD-M1	0.3	1	Cochlear Schwannoma/NF2	MED-EL Synchrony Flex 28	FS4-P	R	25.0	4
M3	SSD-M2	1.3	0.31	Idiopathic progressive	MED-EL Synchrony Flex 28	FS4-P	L	11.7	30
M4	SSD-M3	0.9	2.45	Idiopathic SSHL	MED-EL Synchrony Flex 28	FS4-P	L	26.7	44
M5	SSD-M4	6.6	1.07	Idiopathic SSHL	MED-EL Synchrony Flex 28	FS4-P	L	5.0	DNT
N6	SSD-N1	4.2	8.26	Idiopathic SSHL	Cochlear N512 CI512	ACE	R	43.3	70
N7	SSD-N6	2.4	3.3	Idiopathic SSHL	Cochlear Profile CI512	ACE	R	3.3	84
N8	SSD-N7	0.4	4.21	Idiopathic SSHL	Cochlear Profile CI512	ACE	R	15.0	48
N9	SSD-N8	1.1	1.56	Genetic	Cochlear Profile CI532	ACE	L	8.3	92
N10	SSD-N9	9	0.79	Temporal bone fracture	Cochlear Profile CI512	ACE	L	16.7	66
N11	SSD-N10	3.2	1.95	Idiopathic SSHL	Cochlear Profile CI532	ACE	R	26.7	70

For simplicity, subjects are referred to in this manuscript by subject code (i.e., C1-N11). The letter before the number refers to the manufacturer of the device (“C”: Advanced Bionics; “M”: MED-EL, and “N”: Cochlear). The internal lab code for each subject is also provided for comparison purposes to other publications. Dur deaf = duration of deafness. CI exp = cochlear implant experience. AB = Advanced Bionics. ACE = Advanced Combination Encoder. PTA = pure-tone average thresholds across 500, 1000, and 2000 Hz. DNT = did not test. For all subjects except for C1, M3, and M5, CNC scores with the CI-only were obtained after 1 year of CI experience. For C1 and M3, scores were obtained after 3 months of CI experience; no scores were available for M5.